Antiretrovirals|OMICS International|Epidemology : Viral Diseases

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Epidemology : Viral Diseases

Journal of antivirals & antiretrovirals is one of the best open access journals in the field of virology. The open access policy of the journals mainly aims at increasing the visibility and accessibility of the published quality work and thus providing the desirable researches to the readers. The journal studies about the epidemiology, It is the study of determinants, dynamics and distribution of viral diseases in the population. It is very difficult to measure the rate of chronic disease, where the onset of spread is insidious. There is continual variation in study of viral epidemics regarding clinical symptoms, duration, disappearance and the emergence of new diseases. This can be observed in both human and animal diseases. The evolution of viral diseases is mainly due to three factors such as etiological agent, host and environment. The genetic alterations observed in viruses are caused mainly due to two major mechanisms involved 1) Mutations such as recombination and assortment; and selection for resistance or susceptibility. OMICS Group international is the best open access publishers with expert reviewers and renowned scientists in its Editorial Board. Both editors and reviewers actively participate in the peer-review process and help in completing the review process within time. Omics group is now providing an opportunity to authors to share their valuable research on virology across linguistic borders in different languages such as French, German, Spanish, Chinese, Japanese, and English. By translating scientific paper into the mentioned languages we ensure an efficient exchange of knowledge and scientific experience.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on May, 2021